Hi-Clearance Inc. (TPEX:1788)
Taiwan · Delayed Price · Currency is TWD 137.50
0.00 (0.00%)
Oct 31, 2025, 1:30 PM CST
Hi-Clearance Revenue
Hi-Clearance had revenue of 1.07B TWD in the quarter ending June 30, 2025, a decrease of -2.45%. This brings the company's revenue in the last twelve months to 4.13B, up 2.56% year-over-year. In the year 2024, Hi-Clearance had annual revenue of 4.07B with 4.54% growth.
Revenue (ttm)
4.13B
Revenue Growth
+2.56%
P/S Ratio
1.48
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.07B | 177.03M | 4.54% |
| Dec 31, 2023 | 3.90B | -793.91M | -16.93% |
| Dec 31, 2022 | 4.69B | 1.01B | 27.30% |
| Dec 31, 2021 | 3.68B | 252.04M | 7.34% |
| Dec 31, 2020 | 3.43B | 191.25M | 5.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| PharmaEssentia | 12.63B |
| Pegavision | 6.90B |
| Center Laboratories | 1.60B |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |
| Caliway Biopharmaceuticals | 44.83M |